Corporate GovernanceApr 28, 2026, 05:17 PM
BLFS Amends 2025 10-K for Corporate Governance, Compensation
AI Summary
BioLife Solutions, Inc. filed Amendment No. 1 to its 2025 Annual Report on Form 10-K/A because it does not intend to file a definitive proxy statement for its 2026 Annual Meeting within 120 days. This amendment restates Part III, Items 10 through 14, covering directors, executive officers, corporate governance, executive compensation, security ownership, related transactions, and principal accountant fees. It also includes new certifications from the principal executive and financial officers, and details recent management changes.
Key Highlights
- Amendment No. 1 to 2025 Form 10-K filed due to delayed proxy statement for 2026 Annual Meeting.
- Restates Part III, Items 10-14, covering directors, executive officers, corporate governance, executive compensation, and security ownership.
- Includes new certifications from principal executive and financial officers.
- Karen Foster retired as Chief Quality and Operations Officer effective March 31, 2026.
- Sarah Aebersold's Chief Human Resources Officer position was eliminated as of March 20, 2026.
- Several Section 16(a) filings were late in 2025 for multiple executives and a 10% owner.
- Aggregate market value of common equity held by non-affiliates was approximately $845 million as of June 30, 2025.
- 48.9 million shares of common stock were outstanding as of April 21, 2026.
Price Impact
More from BLFS